Case Comprehensive Cancer Center
February 19, 2021
Please join the Case Comprehensive Cancer Center in extending congratulations to Cleveland Clinic's Jacob Scott, MD, DPhil on his recent election to the American Society for Clinical Investigation (ASCI), which recognizes outstanding scholarly achievement among physician-scientists. Dr. Scott will…
February 19, 2021
The Youth Engaged in Science (YES) Program, led by Nathan A. Berger, MD, kicked off its spring session with a new "Learn to Beat Cancer" cohort this past Saturday. Eight middle school students, their families and a middle school teacher joined a Zoom-based virtual classroom, where they learned the…
February 12, 2021
A team of researchers from CWRU and UH is investigating the role of Erbb3 in the development of colorectal cancer. To put it simply, says lead investigator Zhenghe John Wang, PhD, the team is attempting to discover the pathways that can switch the cold tumors to hot tumors, and activate immune…
February 12, 2021
Dear Members of the Cancer Center community, Next month, on March 4-5, we are hosting the 5th Annual Cancer Disparities Symposium, themed as “Navigating Cancer Disparities: Lessons Learned and How to Move Forward.” This symposium has attracted a diverse audience as we will not only be joined by…
February 12, 2021
From Cleveland Clinic Lerner Research Institute: Machine learning-based approaches to risk assessment can be highly effective in predicting various types of cardiac dysfunction among cancer survivors who have received cardiotoxic cancer therapies, according to a new retrospective longitudinal study…
February 12, 2021
The Case Comprehensive Cancer Center extends congratulations to Cleveland Clinic's Abhishek Chakraborty, PhD as he was awarded a 2020 V Scholar Grant from the V Foundation for Cancer Research for his proposal, "Chromatin Dysfunction Identifies Metabolic Regulators as Potential Therapeutic Targets…
February 05, 2021
Glioblastoma, recognized as the most aggressive primary brain cancer in adults is also known to be among the most immunosuppressive of tumors. A Phase 2 clinical trial of PVSRIPO, a revolutionary viral immunotherapy for cancer treatment, in combination with Keytruda (pembrolizumab) is underway…
February 05, 2021
Research into stopping tumor growth was recently featured in BBC Science Focus Magazine as one of the world's "20 moments in 2020 to be excited about." A compound that activates an enzyme capable of suppressing tumors was discovered by a cross-institutional team from the University of Michigan and…
February 05, 2021
From Cleveland Clinic Lerner Research Institute: Standard-of-care treatment for many cancers includes chemotherapy drug cisplatin which prevents the spread of cancer cells by interrupting DNA replication and damaging the genetic material in rapidly dividing tumor cells. Unfortunately, the drug can…
January 29, 2021
Ohio Governor Mike DeWine and Lt. Governor Jon Husted on Monday announced the Cleveland Innovation District, a transformational collaboration of Northeast Ohio's leading healthcare and higher education institutions. The Cleveland Innovation District brings together Case Western Reserve University,…